It is now recognized that CD3' large granular lymphocyte ( L W prolierations may be clonally derived from their normal CD3+LGL+ counterpart, but the nature of the pressure responsible for the prolieration of these cells remains unclear. We approached this problem by analyzing the diversity of the T-cell receptor repertoire of LGL developed in different clinical settings. Two of our patients had typical lymphoproliferative disorders. The third case was much more unusual, as the LGL proliferation was associated with a Wiskott-Aidrich syndrome. Our data relative to the patients with the lymphoproliferative disorders only suggest that these LGL were clonally expanded. The data relative to the patient with Wiskott-Aldrich syndrome were more unexpected, as the T-CENTRAL QUESTION concerning the nature of lymphoproliferative disease of large granular lymphocytes (LGL) is whether it represents a neoplastic or a reactive disorder. Because of their generally chronic and indolent clinical course, LGL proliferations were for many years believed not to be monoclonal leukemia. The discovery of the genomic organization of the T-cell receptor (TCR)',2 and the consequent possibility of defining T-cell clonality using TCR probes in Southern blot analysis? have, however, greatly contributed to the revision of this belief. It is now recognized that the majority of CD3+ LGL are clonally derived from their normal counterpart: but the nature of the pressure responsible for the expansion of these cells remains unclear. The demonstration of TCR clonal rearrangements of LGL4"" does not necessarily imply a neoplastic transformation, as oligoclonal T-cell populations have been detected in several human disease^""^ and in patients with severe combined immunodeficiency (SCID) and maternal engraftment.'* Furthermore, clonal T-cell populations have been found within the CDVCD45RO' subset" and in elderly2" normal human lymphocytes, as well as in CD8+CD57' T cells prepared from normal individuals and rheumatoid arthritis patients." These findings demonstrate that in vivo selective pressures can also be responsible for the expansion of clonal or oligoclonal cell populations. Thus, LGL were characterized by the clonal expansion of a few TCRBV segments that shared common amino acid motifs in the junctional region of the T-cell receptor. This common pattern of junctional diversity associated with different TCRBV segments is, therefore, consistent with a strong ongoing antigenic selection process, possibly related to the pathogenesis of Wiskott-Aldrich syndrome. Furthermore, the finding that the same TCRBV segments were also highly expanded among other T-cell subpopulations questions the malignant nature of this LGL proliferation.
It is now recognized that CD3' large granular lymphocyte ( L W prolierations may be clonally derived from their normal CD3+LGL+ counterpart, but the nature of the pressure responsible for the prolieration of these cells remains unclear. We approached this problem by analyzing the diversity of the T-cell receptor repertoire of LGL developed in different clinical settings. Two of our patients had typical lymphoproliferative disorders. The third case was much more unusual, as the LGL proliferation was associated with a Wiskott-Aidrich syndrome. Our data relative to the patients with the lymphoproliferative disorders only suggest that these LGL were clonally expanded. The data relative to the patient with Wiskott-Aldrich syndrome were more unexpected, as the T-CENTRAL QUESTION concerning the nature of lymphoproliferative disease of large granular lymphocytes (LGL) is whether it represents a neoplastic or a reactive disorder. Because of their generally chronic and indolent clinical course, LGL proliferations were for many years believed not to be monoclonal leukemia. The discovery of the genomic organization of the T-cell receptor (TCR)',2 and the consequent possibility of defining T-cell clonality using TCR probes in Southern blot analysis? have, however, greatly contributed to the revision of this belief. It is now recognized that the majority of CD3+ LGL are clonally derived from their normal counterpart: but the nature of the pressure responsible for the expansion of these cells remains unclear. The demonstration of TCR clonal rearrangements of LGL4"" does not necessarily imply a neoplastic transformation, as oligoclonal T-cell populations have been detected in several human disease^""^ and in patients with severe combined immunodeficiency (SCID) and maternal engraftment.'* Furthermore, clonal T-cell populations have been found within the CDVCD45RO' subset" and in elderly2" normal human lymphocytes, as well as in CD8+CD57' T cells prepared from normal individuals and rheumatoid arthritis patients." These findings demonstrate that in vivo selective pressures can also be responsible for the expansion of clonal or oligoclonal cell populations. the apparently conflicting results concerning the monoclonal4"' or p o l y~l o n a l~~~~~ nature of LGL expansions can be conciliated by proposing that the initial stage of the disease is characterized by polyclonal expansions, from which oligoclonal populations can subsequently be selected as the consequence of antigenic pressure by unknown ligandsx In accordance with this hypothesis, Kasten-Sportss et have recently reported that the LGL population of a patient, characterized by the monoclonal expression of one TCRBV segment, used a common TCRAV chain that was associated with a multiplicity of N region additions and TCRAJ segment rearrangements. This result has been interpreted as the action of an immune selection-mediated process, occurring at an early stage of cell maturation that may have contributed to the selection of this particular clone.
Recently, a patient with Wiskott-Aldrich syndrome (WAS) who presented with lymphocytes with morphologic characteristics of LGL was referred to the Department of Paediatrics of the Spedali Civili of Brescia, Italy. WAS is an X-linked disorder characterized by severe thrombocytopenia, eczema, and profound immunodeficiency involving both B and T l y m p h o~y t e s .~'~~~ Although WAS is associated with an increased risk of malignancies, particularly lymphoreticular tumors and leukemia,?" LGL proliferations are probably rare in primary immunodeficiencies, as they have been so far detected only in a patient with Ataxia Telangiectasia.?' The availability of LGL developed in an unusual clinical context provided a unique opportunity for further defining the nature of the selective pressure responsible for LGL expansions. In this study, therefore, we analyzed, at the molecular level, the TCRBV repertoire of the LGL population expanded in the peripheral blood of this patient. Our data demonstrate that the repertoire of all T-cell populations analyzed are characterized by the clonal expansion of different TCRBV segments that share common motifs at the junctional regions, a condition that clearly distinguishes this patient from the others studied. Table 1 , while the two-color fluorescence analysis performed on patient FC at the time of the present study is summarized in Table 2 .
Using light microscopy, the morphology of LGL was similar in all cases. The LGL were medium-sized cells with moderate to abundant pale blue cytoplasm containing azurophilic granules. The cells were phosphatase-and beta-glucuronidase-positive. 
Lymphocytes preparation.
Blood samples from patient FC were obtained on two different occasions, while a single sample was obtained from patients E R , IT, and FS. Samples from children and adult normal healthy donors were included in this study as control material. Peripheral blood mononuclear cells were obtained after Ficoll Hypaque gradient centrifugation, and different lymphocyte subpopulations were prepared using magnetic microspherical beads coated with specific monoclonal antibodies (MoAbs) and DETACHaBEAD (Dynabeads N-450; Dynal, Oslo, Norway), according to the manufacturer's instructions. Four different subpopulations were obtained from the blood of patient FC (CD8+CD57', CD8'CD57-, CD8-CD57'.
and CD8-CD57-), while the cells of patients FLR and IT were separated in CD8+ and CD8-subsets. As CD8+LGL+ represented the vast majority of the total T-cell population of patient FS, no cell separation was performed in this sample. The purity of cell preparations was analyzed by cytofluorimetry after each step of the preparations. Preparation of RNA, cDNA synthesis, and arnpliJication of cDNA by polymerase chain reaction (PCR). Total RNA was prepared by the guanidinium thiocyanate-phenol-chloroform method from total lymphocytes or lymphocyte subpopulations. One microgram of total RNA was used to synthesize the first strand of the TCRB chainspecific complementary DNA (cDNA) using the RiboClone cDNA Synthesis System (Promega Corp, Madison, WI) and a primer specific for TCRBC1 and TCRBC2 genes (PcDNA: 5' GGG CTG CTC For personal use only. on November 16, 2017. by guest www.bloodjournal.org From Extrapolated from the relative percentage of LGL distribution.
CTT GAG GGG CTG CGG 3'). The cDNA was then subjected to enzymatic amplification using a second human TCRBC primer @AI: S' CCC ACT GTG CAC CTC CTT CC 3') and a TCRBV degenerated primer [Vpd: S' ACG TGA ATT CT(GT) T(ACT)(CT) TGG TA(CT) (AC)(AG)(AT) CA 3'1, which was designed to amplify TCRB chain rearrangements containing virtually all the known human TCRBV genes." The original sequence of this primer was modified by adding at the S' end an EroRI restriction site. The PCR products are about 400 base pairs long: they contain one half of the V region gene and extend through the V-D-J junction to the TCRBC region. The cycles of PCR were performed under the following conditions: denaturation at 93°C for I minute, annealing at 52°C for I minute. and extension at 72°C for I minute. The last cycle extension was performed at 72°C for 7 minutes. The specificity of the total amplified products was analyzed using the previously described colorimetric method and biotinylated TCRBV-specific probes. Subsequently, the TCRBV chains of interest were amplified by PCR using TCRBV-specific family primers (TCRBVI: S' GCA CAA CAG TTC CCT GAC TTG CAC 3': TCRBV2: S' TCA TCA ACC ATG CAA GCC TGA CCT 3': TCRBV 13s I : S' CAA GGA GAA GTC CCC AAT 3'; TCRBV13S2: S' GGT GAG GGT ACA ACT GCC 3': TCRBV14: S' GTC TCT CGA AAA GAG AAG AGG AAT 3': TCRBVIS: S' ACT GTC TCT CGA CAG GCA CAG GCT 3'; TCRBV17: S' CAG ATA GTA AAT GAC TTT CAG 3': and TCRBVZO: S' AGC TCT GAG GTG CCC CAG AAT CTC 3') and a TCRBC oligonucleotide (BAl). Clonin'q crnrl .sc,clrrcwcin,y of PCR products. The PCR products LGL. Because a fraction of CD8' lymphocytes were CDS7-. we initially studied the repertoire of the CDg'CDS7-subset. We observed that these lymphocytes were characterized by the preferential use of TCRBV13SI. TCRBV13S2. TCRBV17. and TCRBV22 segments (data not shown). To understand whether this peculiar pattern of TCRBV use was a characteristic of LGL expressing the typical CD8TDS7' phenotype only. we extended the analysis to the CD8'CDS7-, CD8-CDS7'.
and CD8-CDS7-subpopulations prepared from a second sample of blood. obtained 3 months later. Detailed two-color immunophenotyping was undertaken by flow cytometer to determine the purity of each cell separation. After beads detachment.
869 of purified CD8' cells (98% viable and 99% pure) coexpressed the CD3 marker; 83% of these isolated CD8-lymphocytes were CD8'CDS7', and only 1.7% were CD4'CDS7*. The CD% cell preparation still contained 1 1 % of contaminating cells expressing the CD8 marker, at low density. These contaminating cells, however. were CD3-. The CD8TDS7-prepa- ration was contaminated by 10% of cells coexpressing CD8 and CD57 markers, while separated CD8-CD57-cells contained only 1% of CDSTD57' lymphocytes. The distribution of LGL in the different cell preparations is shown in Table 3 . Surprisingly, we found that the TCRBV13S1, TCRBV13S2, TCRBV17, and TCRBV22 segments were dominantly expressed not only on the CD8+CD57+ cells, but also on the CDVCD57-and CDSTD57+ subsets, and, furthermore, we also detected the expansion of the TCRBV24 segment in two of the three cell populations analyzed and an increased expression of TCRBV14 in CD8-CD57+ lymphocytes (Fig I) . We did not obtain any amplification product from CD8-CD57-cells, probably because the number of recovered cells, after the two negative separations by magnetic beads, was below the detection capability of the degenerated PCR assay. The abnormal expansion of only few TCRBV chains in patient FC did not appear to be selectively related to WAS, because the TCRBV profile of CD8+ and CD8-lymphocytes prepared from a second patient with this immunodeficiency, in the absence of LGL proliferation (Fig 2) , did not deviate significantly from that of normal individuals. The nature (monoclonal or polyclonal) of the TCRBV expansions observed in patient FC was determined by nucleotide sequencing of the V-D-J junctions of the expanded segments. More precisely, we analyzed the junctional regions of TCRBV13S2 cDNA clones derived from CD8+CD57+, CD8'CD57-, and CDKCD57+ lymphocytes and of TCRBV17 clones prepared from CD8+CD57+ and CD8+CD57-cells. We also sequenced TCRBV13S1 clones obtained from purified CD8+CD57+ lymphocytes and TCRBV14 chains derived from CD8+CD57+ and CD8-CD57+ cells. The majority of TCRBV13S2 sequences derived from both CD8+CD57+ and CD8+CD57-cells used the same TCRBJ segment and the same NDN junctional sequence, suggesting that TCRBV13S2 enrichment is due to the expansion of a dominant clone (Fig 3, left) . Interestingly, six of the eight TCRBV13S2 clones derived from the CDKCD57' cells contained an NDN region identical to that of the dominant CD8TD57' clone, with the only exception being a C-to-A nucleotide substitution that resulted in a replacement of aspartic acid by alanine. Furthermore, the clone derived from CD8-CD57+ cells and bearing the TCRBJ2S 1 ,.. ,.,
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region had a junctional sequence closely related to the identical TCRBJ2S7 clones found in the CD8+CD57+ and CDS'CD57-lymphocyte subsets. Because the CDS'CD57-cell population contained only 10% of LGL, these data suggest that, in this patient, the expansion of closely related and still differentiating clones expressing TCRBV13S2 may not be selectively restricted to LGL.
The analysis of TCRBV17 segments derived from both CD8+CD57+ and CDVCD57-T-cell subsets also revealed a pattern of rearrangement that defined the dominant presence of transcripts encoding the same TCRBJlSl segment and the identical junctional region (Fig 3, right) . Similar molecular analysis of the TCRBV13S 1 segment confirmed the expansion of a dominant clone in the CD8+CD57+ lymphocytes. Strikingly, the TCRBV13S1 clone contained, at the first three positions of the NDN region, the same prolineserine-serine motif that characterized the junctional region of the TCRBV17 transcript. Thus, although these clones use different TCRBV and TCRBJ segments, it is likely that they may have been selected by the same, or closely related, dominant T-cell epitope. To determine whether oligoclonality was also detected in cells expressing less dominant TCRBV segments, we also analyzed TCRBV14 transcripts derived from CDS+CD57+ and CDS-CD57+ cells. TCRBV14 transcripts derived from CD8'CD57+ cells were characterized by polyclonal V-D-J rearrangements, and there was no evidence of clonal selection. The sequence analysis of TCRBV14 transcripts expressed by CDS-CD57+ cells, on the other hand, revealed a completely different pattern of rearrangements that defined the dominant presence of a group of sequences encoding the same TCRBJ2S5 segment and a stop codon in the third hypervariable (CDR3) region. Because this nonfunctional transcript was found to be highly represented in the CD8-CD57+ lymphocytes, it is likely that it represents the product of the nonfunctionally rearranged allele of the dominant clone, detected in the same subset and expressing the TCRBV13S2 segment.
TCRBV use in patients with LGL proliferation not associated with WAS. To establish whether the unusual LGL clonal expansions detected in patient FC are typical of this clinical setting or reflect a more general property of LGL transformation, we extended the analysis of the TCR repertoire to two additional patients affected by a lymphoprolifer- ative disorder but not by WAS. The PCR analysis of lymphocytes from patient FS showed a dramatic expansion of the TCRBVIS segment, which is expressed at a very low level in lymphocytes obtained from normal subjects, as well as an increase of the TCRBVl segment (Fig 4) . The analysis of cDNA clones revealed the presence of only one rearrangement in TCRBVlS transcripts, while TCRBVl clones were characterized by a polyclonal pattern of V-D-J junctions (Fig 4) .
Similar results were obtained with patient IT. In this case, due to coexistence of CD8+ LGL and normal CD4+ T cells in the blood circulation, we analyzed the TCRBV chain use by separated CD8+ and CD8-cell populations. TCRBV20 cDNA clones derived from CD8+ and CD8-cells were monoclonal in the first subset (20 identical V-D-J sequences) and polyclonal in the second (Fig S) . The sequence analysis of another randomly chosen TCRBV segment, such as TCRBV2, confirmed the polyclonality of CD8+ cells bearing this molecule. In conclusion, the strict monoclonality of the LGL proliferations observed in these two patients contrasts sharply with the more complex pattern of clonal expansions detected in the patient with WAS, and collectively, the data underscore the complexity of this lymphoproliferative disorder.
DISCUSSION
In this study we analyzed the diversity of the TCRBV repertoire of LGL developed in different clinical settings.
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Two of our patients had typical lymphoproliferative disorders characterized by the expansion of CD8+LGL+. The third case was much more unusual, as the expansion of the LGL subset was associated with WAS. The long-lasting presence of LGL in this patient excludes the presence of a transient lymphocytosis with LGL features, which is usually associated with viral infections?'.40 The total number of circulating LGL in this patient was constantly below 2,0OO/pL, ie, the cut-off value currently accepted as diagnostic criteria.' However, clonal LGL proliferations have also been detected in patients with lower absolute numbers of circulating LGL.4,"" WAS is an X-linked recessive immunodeficiency characterized by eczema, bloody diarrhea, recurrent and increased risk of autoimmune diseases!2 Because T-cellmediated autoimmune disorders have been postulated to be involved in LGL expansion: we reasoned that the repertoire analysis of this patient could be extremely rewarding for understanding the putative role of the immunologic selection process in establishing this proliferative syndrome. Our data relative to patients FS and IT, affected by a classic lymphoproliferative disorder, confirm and extend previous studies suggesting that at least some LGL proliferations are clonally derived from the pool of the normal lymphocyte~.~ In these two patients, we observed that the circulating CD8+ lymphocyte subsets were characterized by the dominant expression of one TCRBV segment, TCRBV 15 and TCRBV20, respectively, with monoclonal rearrangements. The other cell populations analyzed had a polyclonal pattern of V-D-J junctions. These data are, therefore, consistent with a classical model of neoplastic clonal evolution, due to the combined action of genetic and environmental factors on a single cell.
The data relative to the patient with WAS are more intriguing and collectively imply that the natural history of LGL proliferation can be more complex than previously appreciated. The TCRBV repertoire of this patient was characterized by the expression of few TCRBV segments only; however, these transcripts were dominantly expressed on T-cell subpopulations with different phenotypes. Surprisingly, we found that an almost identical and monoclonal TCRBV13S2 transcript was dominantly expressed by both CD8+CD57+ and CD8-CD57+ cells. The only feature that differentiated the two transcripts was the substitution of aspartic acid with alanine at the NDN joining region. It is possible, therefore, TCRBV CHAINS that the selection of a limited number of TCRBV chain molecules had occurred in still differentiating CD8-and CD4-cells, before the differentiation event that leads to the acquisition of the LGL phenotype. Relevant to this point is the observation that CD4-CD8-TCRAB+ cells, which are capable of recognizing bacterial antigens, are often oligoclor~al.~~." Alternatively, the expression of this TCRBV segment can be a common feature of different clones selected after their acquisition of the CD8+ and CD8-phenotype. However, the finding that the monoclonal TCRBV transcripts were dominantly expressed by both CD8+CD57+ and CD8+CD57-lymphocytes further supports the hypothesis of the differentiative capability of the originally selected cells.
A more trivial explanation for these results is that the clonality of the CD8-cells was due to CD8+ contaminants present in the CD8-preparation. This possibility, however, is unlikely because CD8+ low density cells were present only in small numbers in the CD8-cell population. Furthermore, all CD8+ cells contaminating the CD8-preparation did not express CD3 marker, and, therefore, they probably do not productively transcribe TCR segments.
The most surprising finding of this study was that the dominant and monoclonal TCRBV 17 and TCRBV 13s 1 transcripts expressed by patient FC had closely related junctional sequences. This is highly unlikely to occur by chance alone, if one considers the very large number of possible combinations of V-D-J segments and N additions. Therefore, this common pattern of junctional diversity is consistent with a strong antigenic selection process, possibly due to the particular clinical setting of the patient. Based on the structure of immunoglobulins, current models of TCR predict the existence of three major CDRs (CDRl, CDR2, CDR3) on both TCRA and TCRB chains.45 The CDR3 loop is formed by the joining of the V-D-J segments and interacts predominantly with determinants on the bound peptide of the antigen/ major histocompatibility complex (MHC).45-47 Thus, our data suggest that, although the dominant TCRBV17 and TCRBV13S1 clones use different TCRBV segments, they have both been selected by a common T-cell epitope whose recognition is strictly dependent on the conformational structure of the CDR3 loop. The presence of a proline residue in the first position of the NDN regions of the dominant TCRBV13S1, TCRBV13S2, and TCRBV17 transcripts may also not be causal.
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Our data are, therefore, not compatible with an oncogenic event, but rather suggest the existence of receptor-mediated selective pressures. The nature of the antigen responsible for the selection of the observed clonal dominance can only be speculated at this time. The association between LGL proliferation and autoimmunity has long been suspected, although retroviruses have been implicated as the original pathway of antigen
The hallmarks of WAS are abnormal cell-surface cytoarchitecture:' abnormalities in the pattern of glycosylation of cell-surface protein^:^.^' and defective transmembrane ~ignaling.~' The cytoarchitectural defect may, therefore, induce autoimmune phenomena that may evolve into either malignancies or aberrant clonal expansions. However, we also cannot disregard the possibility that the association between the observed clonal dominance and WAS is only fortuitous. Kasten-Sportb et al, 26 for instance, have recently proposed that LGL expansion may represent a T cell-mediated autoimmune disorder that involves recognition by the TCR of the clonal T cells of an antigen on a protein required for granulopoiesis or erythropoiesis. In addition, oligoclonal evolution may also depend on a number of exogenous microbial or viral agents characterized by the presence of dominant T-cell epitopes. For instance, the human TCR repertoire, developed against defined influenza nuclear protein epitopes, has been shown to be olig~clonal.~~ Similarly, dominant selection of an invariant T-cell antigen receptor is observed in patients with chronic hepatitis C, among intrahepatic T cells specific for the protein NS4 of hepatitis C virus."
In conclusion, our results establish that, at least in our patient, LGL proliferation was due to an antigenic selection process responsible for the expansion of a limited number of T-cell clones, characterized by the expression of different TCRBV segments but with remarkably similar structural constraints in the CDR3 regions. The observation that the TCRBV segments were also highly enriched in other T-cell subpopulations raises important questions concerning the malignant nature of this LGL proliferation.
